NCT07101809

Brief Summary

The goal of this clinical trial is to compare Steerable Ureteroscopic Renal Evacuation (SURE) using the CVAC System and standard ureteroscopy (URS) with laser lithotripsy for the treatment of urolithiasis. This is a prospective, randomized (1:1), multi-center study.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
36mo left

Started May 2026

Typical duration for not_applicable

Geographic Reach
1 country

5 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress6%
May 2026Jul 2029

First Submitted

Initial submission to the registry

July 25, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 3, 2025

Completed
10 months until next milestone

Study Start

First participant enrolled

May 21, 2026

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2027

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2029

Last Updated

July 23, 2026

Status Verified

July 1, 2026

Enrollment Period

1.1 years

First QC Date

July 25, 2025

Last Update Submit

July 22, 2026

Conditions

Keywords

ureteroscopyCVACSURE

Outcome Measures

Primary Outcomes (1)

  • Residual Stone Volume (RSV)

    30-Day

Study Arms (2)

Standard Ureteroscopy (URS)

ACTIVE COMPARATOR

This is a treatment in which the urologist uses a laser to break a kidney stone into very small pieces and then places a tool called a stent to allows the remaining pieces to fall out.

Device: Standard Ureteroscopy (URS)

Steerable Ureteroscopic Renal Evacuation (SURE) with CVAC System

ACTIVE COMPARATOR

The CVAC Aspiration System is a sterile, single use, steerable ureteral catheter system with integrated vision, irrigation and aspiration for the treatment and removal of urinary stones (kidney stones, fragments, and dust).

Device: Steerable Ureteroscopic Renal Evacuation (SURE) using the CVAC System

Interventions

The CVAC Aspiration System is a sterile, single use, steerable ureteral catheter system with integrated vision, irrigation and aspiration for the treatment and removal of urinary stones (kidney stones, fragments, and dust).

Also known as: CVAC
Steerable Ureteroscopic Renal Evacuation (SURE) with CVAC System

Arm Description: This is a treatment in which the urologist uses a laser to break a kidney stone into very small pieces and then places a tool called a stent to allows the remaining pieces to fall out.

Standard Ureteroscopy (URS)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Candidate for ureteroscopy with laser lithotripsy
  • Be willing and able to return for and respond to all study-related follow up procedures
  • Have been informed of the nature of the study and has provided informed consent using the IRB approved informed consent (ICF)

You may not qualify if:

  • Untreated urinary tract infection at the time of the index procedure
  • Significant comorbidities
  • Bladder, ureteral or kidney abnormalities
  • Pregnant individuals
  • Unable to meet the treatment and follow up protocol requirements

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

The University of Alabama at Birmingham

Birmingham, Alabama, 35294, United States

RECRUITING

University of Florida

Gainesville, Florida, 32611, United States

RECRUITING

Icahn School of Medicine at Mount Sinai

New York, New York, 10029, United States

RECRUITING

MidLantic Urology

Bala-Cynwyd, Pennsylvania, 19004, United States

RECRUITING

The University of Texas at Austin, Dell Medical School

Austin, Texas, 78712, United States

RECRUITING

MeSH Terms

Conditions

UrolithiasisKidney CalculiNephrolithiasis

Condition Hierarchy (Ancestors)

Urologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesKidney DiseasesUrinary CalculiCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 25, 2025

First Posted

August 3, 2025

Study Start

May 21, 2026

Primary Completion (Estimated)

July 1, 2027

Study Completion (Estimated)

July 1, 2029

Last Updated

July 23, 2026

Record last verified: 2026-07

Locations